Emily was 33 at the time of her yearly check-up in 2018. Unlike most women her age, she was finding it hard to keep up with her students in the school she taught at in Toronto, Canada. Her knees and hips were aching, and her weight seemed like it was out of her control. At 280lb (20st), she knew she was approaching a point of no return. Her doctor listened to her ailments and then delivered his own set of bad news. She had type 2 diabetes. They needed to act fast to get her illness into remission. Emily was not a fan of taking medication. But her thoughts drifted to her uncle, who’d had diabetes and suffered from a litany of painful complications like arthritis until he died in his fifties. She would do everything she could to avoid his fate, so when her doctor told her about a great new drug that had just been approved for diabetes, she didn’t ask too many questions. As for many in her situation, this seemed like a lifeline, and she’d be crazy not to take it. Emily’s doctor explained how the medication, Ozempic, was a game-changer because, unlike drugs like metformin
Read More











